TherapeuticsMD, Inc.
TXMD
$1.10
$0.01991.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 952.00K | 393.00K | 667.00K | 547.00K | 234.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 952.00K | 393.00K | 667.00K | 547.00K | 234.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 952.00K | 393.00K | 667.00K | 547.00K | 234.00K |
| SG&A Expenses | 1.18M | 1.08M | 879.00K | 1.31M | 1.23M |
| Depreciation & Amortization | 96.00K | 95.00K | 100.00K | 96.00K | 180.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.27M | 1.18M | 979.00K | 1.41M | 1.41M |
| Operating Income | -319.00K | -783.00K | -312.00K | -859.00K | -1.18M |
| Income Before Tax | 545.00K | -668.00K | 83.00K | -567.00K | -1.05M |
| Income Tax Expenses | -- | -32.00K | -31.00K | -- | -- |
| Earnings from Continuing Operations | 545.00K | -636.00K | 114.00K | -567.00K | -1.05M |
| Earnings from Discontinued Operations | 6.00K | -17.00K | 138.00K | -42.00K | -40.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 551.00K | -653.00K | 252.00K | -609.00K | -1.09M |
| EBIT | -319.00K | -783.00K | -312.00K | -859.00K | -1.18M |
| EBITDA | -223.00K | -688.00K | -212.00K | -763.00K | -999.00K |
| EPS Basic | 0.05 | -0.06 | 0.02 | -0.05 | -0.09 |
| Normalized Basic EPS | 0.03 | -0.03 | -0.06 | -0.03 | 0.01 |
| EPS Diluted | 0.05 | -0.06 | 0.02 | -0.05 | -0.09 |
| Normalized Diluted EPS | 0.03 | -0.03 | -0.06 | -0.03 | 0.01 |
| Average Basic Shares Outstanding | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M |
| Average Diluted Shares Outstanding | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |